Pharmacokinetics of AGO178 in Participants With Liver Impairment

NCT01531309 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: AGO178

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]